SCHEMBL29155482

SCHEMBL29155482

CC(=O)N1C[C@@H](C(=O)O)CCC1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.45
ATM Q13315 1/20 0.40
GAA P10253 1/20 0.38
TSHR P16473 3/20 0.37
ALDH1A1 P00352 1/20 0.35
NOTUM Q6P988 5/20 0.33
PLG P00747 1/20 0.32
PLAT P00750 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
APLNR P35414 1/20 0.31
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23163268 1.00 MAPT (0.45) MAPTATMGAATSHRALDH1A1
SCHEMBL29155481 1.00 MAPT (0.45) MAPTATMGAATSHRALDH1A1
SCHEMBL28087182 0.86 MAPT (0.47) MAPTGAATSHRALDH1A1NOTUM
SCHEMBL28087184 0.86 MAPT (0.47) MAPTGAATSHRALDH1A1NOTUM
SCHEMBL22122686 0.82 MAPT (0.44) MAPTATMGAATSHRALDH1A1
SCHEMBL23163290 0.82 MAPT (0.44) MAPTATMGAATSHRALDH1A1
SCHEMBL29277771 0.82 MAPT (0.44) MAPTATMGAATSHRALDH1A1
SCHEMBL26123886 0.81 MAPT (0.47) MAPTGAATSHRALDH1A1NOTUM
Acetic Acid SCHEMBL22123508 0.80 MAPT (0.39) MAPTATMGAATSHR
SCHEMBL24150486 0.79 MMP2 (0.44) MAPTGAATSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116113417-A Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of fibrotic diseases 托雷莫治疗股份公司 2023-05-12 CN disclosed
CN-115996717-A Combination of CBP/P300 bromodomain inhibitors and KRAS inhibitors for the treatment of cancer 托雷莫治疗股份公司 2023-04-21 CN disclosed